J R Van Nagell

Title: J R Van Nagell: Innovator in Ovarian Cancer Biomarkers

Introduction

J R Van Nagell is a prominent inventor based in Lexington, KY (US). He has made significant contributions to the field of medical diagnostics, particularly in the area of ovarian cancer. His work focuses on the development of biomarkers that can aid in the classification and diagnosis of ovarian cancer.

Latest Patents

J R Van Nagell holds a patent for "Biomarkers for ovarian cancer." This invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. The biomarkers developed in this patent are instrumental in classifying a subject sample as ovarian cancer, ovarian cancer of low malignant potential, benign ovarian disease, or other malignant conditions. Notably, these biomarkers can be detected using SELDI mass spectrometry.

Career Highlights

Throughout his career, J R Van Nagell has worked with notable organizations, including Vermillion Corporation and the University of Kentucky Research Foundation. His expertise in the field has allowed him to contribute to advancements in cancer diagnostics and patient care.

Collaborations

J R Van Nagell has collaborated with esteemed colleagues such as Eric Thomas Fung and Frederick R Ueland. These partnerships have further enhanced his research and development efforts in the medical field.

Conclusion

J R Van Nagell's innovative work in ovarian cancer biomarkers exemplifies the impact of research and invention in improving medical diagnostics. His contributions continue to influence the field and provide valuable insights for patient care.